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should be addressed
to M G Mohaupt
Email
markus.mohaupt@insel.chAbstractPre-eclampsia leads to disturbed fetal organ development, including metabolic syndrome,
attributed to altered pituitary-adrenal feedback loop. We measured cortisol metabolites
in infants born from pre-eclamptic and normotensive women and hypothesised that
glucocorticoid exposure would be exaggerated in the former. Twenty-four hour urine was
collected from infants at months 3 and 12. Cortisol metabolites and apparent enzyme
activities were analysed by gas chromatography-mass spectrometry. From 3 to 12 months,
excretion of THS, THF and pregnandiol had risen in both groups; THF also rose in the
pre-eclamptic group. No difference was observed with respect to timing of the visit or to
hypertensive status for THE or total F metabolites (PO0.05). All apparent enzymes activities,
except 17a-hydroxylase, were lower in infants at 12 compared to 3 months in the
normotensive group. In the pre-eclamptic group, only 11b-HSD activities were lower at 12
months.17a-hydroxylase and 11b-HSD activities of tetrahydrometabolites were higher in the
pre-eclamptic group at 3 months (P!0.05). 11b-hydroxylase activity increased in the
pre-eclamptic group at 12 months. Cortisol excretion, determined by increased
11b-hydroxylase, compensates for high 11b-HSD-dependent cortisol degradation at
3 months and at 12 months counterbalances the reduced cortisol substrate availability
in infants born from pre-eclamptic mothers.Key Words
" steroid hormones
" pre-eclampsia
" infants
" urineicen
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(2015) 4, 233–241IntroductionThe fetal adrenal gland and hypothalamic–pituitary axis
(HPA) play important roles during pregnancy. Between
weeks 32 and 34 of gestation, there is a rapid maturation ofthe fetal adrenal cortex, allowing development of a variety
of mechanisms associated with a successful transition
to extrauterine life (1, 2, 3, 4). Frequently, intrauterinesed under a Creative Commons
nported License.
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2–9 4 :234growth restriction (IUGR) and premature delivery are due
to pre-eclampsia (5), a pregnancy-specific syndrome
occurring in w3% of all pregnancies and one of the
leading causes of maternal/perinatal mortality and mor-
bidity worldwide (6, 7). Various organ functions in these
infants are subject to intrauterine developmental repro-
gramming (8, 9), with evidence of decreased pituitary
adrenal feedback control of glucocorticoid maintenance
and an association with metabolic syndrome (10, 11).
Little is known about steroid hormone availability and
metabolism during the early postpartum period in infants.
Fetal exposure to maternal cortisol is low, as it is tightly
regulated by the placental enzyme 11b-hydroxysteroid-
dehydrogenase type 2 (11b-HSD), assumed to protect the
fetus against high active levels of glucocorticoids.
Enhanced maternal ‘stress’, reduced placental cortisol
inactivation due to mechanisms such as a compromised
placental 11b-HSD activity in pre-eclampsia (12) and/or a
hypoxic fetal environment, might lead to increased fetal
exposure to cortisol in pregnancy and during birth
(13, 14, 15). Fetal exposure to exogenous glucocorticoids,
to enhance lung maturation, is a further confounder for
fetal cortisol exposure (16). The premature infant must
counterbalance the hormonal demands of acute critical
stress against those of growth and organ maturation (17).
Corticotrophin-releasing hormone (CRH) challenge testsMetabolism of stero
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Figure 1
Schematic flow diagram representing the steroid hormone pathways
regulating cortisol availability. Progesterone-, corticosterone- and cortisol-
related steroid hormones are labelled blue, green and red respectively.
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Published by Bioscientifica Ltd.in premature infants have demonstrated that the ability of
the pituitary to respond adequately to CRH stimulation
depends not only on the dose of CRH, but also on the
maturity of the pituitary–adrenal axis (18, 19). Two types
of response are conceivable: First, adrenal cortical respon-
siveness could be downregulated at birth due to the
relatively high prenatal glucocorticoid exposure. Second,
given compromised intrauterine development, the adap-
tation to later life requirements for steroid hormone
production could be enhanced by an already dysfunc-
tional central feedback response. As adrenal and central
nervous perfusion is maintained even during fetal distress,
any change might be subtle and only apparent when a
need for sensitive regulation arises.
Though potentially biased by the fact that non-
surviving fetuses cannot be evaluated, we hypothesised
that glucocorticoid exposure is exaggerated after pre-
eclampsia. We aimed to investigate cortisol metabolism
(Fig. 1), at postnatal months 3 and 12 in infants born to
pre-eclamptic and normotensive mothers.
Previous studies have used immunoassays which have
the problem of steroid cross reactivity (20, 21). We have
addressed this problem by utilising gas chromatography-
mass spectrometry (GC-MS) (22). In addition, we have
measured steroids in 24 h urine collections, which enables
a non-invasive assessment of hormonal production ratesid hormones
17-OH-Pregnenolone
17-OH-Progesterone
11-Deoxycortisol
Cortisol
Cortisone
xylase
11β-Hydroxysteroid dehydrogenase
E, THE
THS
F, THF, 5α-THF
Steroid hormone metabolites used to assess a given steroid hormone are
shown in yellow boxes. Enzymes, whose apparent activities have been
calculated within the manuscript, are marked.
This work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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rate in adults, as determined by stabilised isotope dilution
technique (23).Material and methods
Subjects
This study was performed as part of a considerably larger
study comparing infants born to pre-eclamptic and
suitably matched normotensive pregnancies with the
aim of 100 in each group. Although a majority of these
women initially agreed to collect nappies, a number of
these dropped out at 3 months and even more so at 12
months, leaving final group sizes of normotensive
(3 months: nZ50; 12 months: nZ29) and pre-eclamptic
(3 months: nZ45; 12 months: nZ16) pregnancies. Infants
of pre-eclamptic mothers were matched to normotensive
controls by G1 week of gestation age at delivery.
In this cross-sectional study, all parents of the
participants, who were recruited from Leicester Royal
Infirmary Teaching Hospital, gave informed, writtenTable 1 Pregnancy and infant demographic and outcome data fo
Nor
3 months (n)
No. of early-onset PE (%34 weeks)
No. of late-onset PE (O34 weeks)
Max systolic BP (mmHg), median (min, max)
Max diastolic BP (mmHg), median (min, max)
Gestational age at delivery (weeks)
Post conception age (weeks)
Birthweight (g)
Corrected birthweight centile
SGA, n (%)
Gender (male n (%))
24 h urine volume (ml)
Preterm (n (%))
Infant weights at 3 months (g)
12 months (n)
No. of early-onset PE (%34 weeks)
No. of late-onset PE (O34 weeks)
Max systolic BP (mmHg), median (min, max)
Max diastolic BP (mmHg), median (min, max)
Gestational age at delivery (weeks)
Post conception age (weeks)
Birthweight (g)
Corrected birthweight centile
SGA, n (%)
Gender (male n (%))
24 h urine volume (ml)
Preterm (n (%))
Infant weights at 12 months (g)
*P!0.05.
aData presented as either meanGS.D. or median (IQR).
http://www.endocrineconnections.org
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Published by Bioscientifica Ltd.consent to participation on behalf of their infants. The
protocol was approved by the Trent Multicentre Research
Ethics Committee. Infants born from a pre-eclamptic
pregnancy and closely matched (see the previous discus-
sion) infants born to normotensive pregnancies were
eligible for the study. Pre-eclampsia was stringently
defined using the International Society for the Study of
Hypertension in Pregnancy guidelines of systolic blood
pressure of 140 mm Hg or more and diastolic pressure
(Korotkoff V) of 90 mm Hg or more on two occasions after
20 weeks gestation in a previously normotensive woman,
together with proteinuria ofR300 mg/l,R500 mg/day or
R2C on dipstick analysis of midstream urine (MSU) if
24-h collection result was not possible (24). Infants with
low birth weight due to congenital infections such as
cytomegalovirus, dysmorphism, twins, severe cerebral
palsy, congenital heart disease, acute infections, hyaline
membrane disease or other respiratory disease, jaundice,
hypoglycaemia or with a history of urinary tract infec-
tions, urological or renal problems were excluded.
Demographic data for the children were recovered
from the hospital records and are presented in Table 1.r these unpaired cross-sectional samples at 3 and 12 monthsa.
motensive controls Pre-eclampsia (PE)
50 45
12
33
157 (132, 211)
110 (91, 132)
38.8G2.3 37.0G3.1
50.7G2.2 50.2G1.9
3291G584 2730G895*
46 (25, 74) 28 (2, 55)*
6 (12) 20 (44)
29 (58) 22 (49)
602.8G189 611.6G192.6
9 (18) 14 (31)
6180G1023 5474G1243*
29 16
4
12
161 (145, 187)
110 (98, 122)
38.6G2.7 37.6G2.2
90.6G2.7 89.5G2.1
3243G701 2952G850
32 (12, 68) 27 (1, 54)
7 (24) 7 (44)
18 (62) 7 (44)
570G225.7 704.7G330.8
6 (21) 6 (38)
9785G1322 9420G1709
This work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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4–9 4 :236The corrected birthweight percentile for each infant was
computed, correcting for gestational age at delivery,
gender, maternal parity, and BMI (25).Urinary sampling
Urine was collected at postnatal months 3 and 12 months,
over 24 h using pure cellulose disposable nappies provided
in advance to the mothers. A thin gauze was placed
between the baby’s skin and the surface of the inner side of
the nappy to reduce contamination with meconium or
stool (26); samples with diarrhoea were omitted. Nappies
of the appropriate size were changed every 4 h for term
and 8 h for preterm infants and were weighed before and
after urine collections, allowing exact calculation of 24-h
urine output (27).
Nappies were stored in plastic bags at room tempera-
ture until completion of the 24-h collection period and
then stored atK20 8C. The 24-h urine was extracted using
established methods, with recovery of steroid hormones
similar to those previously tested (26). To extract urine,
nappies were defrosted, folded inside out, and placed in a
plastic bag before extraction using a specially constructed
hydraulic press. The extracted urine for the 24-h collection
was pooled and centrifuged. The collected specimens were
stored at K80 8C prior to GC-MS analysis.Assessment of urinary steroid hormones by GC-MS
Steroid hormone measurement by GC-MS was performed
on a Hewlett-Packard gas chromatograph 6890 (Hewlett-
Packard) with mass selective detector 5973 by selective
ion monitoring, as described earlier (28). This method
enabled the following metabolites to be determined:
tetrahydro-deoxycortisol (THS), cortisol (F), cortisone (E),
tetrahydro-F (THF), 5a-THF (5aTHF), tetrahydro-E (THE),
tetrahydro-corticosterone (THB), 5a-Tetrahydro-corticos-
terone (5a-THB), TH-dehydro-B (THA) and pregnandiol.
Total F metabolites were calculated as the sum of the
cortisol and cortisone metabolites. Steroid hormone
concentrations are provided as mg/24 h.
By convention, enzyme activities are calculated by
ratios of various metabolites (29). The enzyme activities
described are therefore apparent activities and not directly
measured. The apparent activity of 17a-hydroxylase was
calculated as the ratio of (THACTHBC5aTHB)/ (THEC
THFC5aTHF) and the apparent 11b-hydroxylase activity
as 100xTHS/(THECTHFC5aTHF). For these apparent
activities, high ratios represent low enzyme activities
and vice versa.http://www.endocrineconnections.org
DOI: 10.1530/EC-15-0084
 2015 The authors
Published by Bioscientifica Ltd.11b-hydroxysteroid dehydrogenase exists in two
forms: 11b-HSD1 and 11b-HSD2. 11b-HSD1 reduces
cortisol to the less active cortisone; the reverse reaction
is also possible. Conversely, 11b-HSD2 irreversibly reduces
cortisol to cortisone. The net cortisol to cortisone balance
in response to a given total 11b-hydroxysteroid dehydro-
genase enzymatic activity was assessed by calculation of
the ratio of F/E and the corresponding ratio of their TH
metabolites (THFC5aTHF)/THE (30).Statistical analyses
Data are summarised as meanGS.D. or median (IQR) as
appropriate for the distribution. Correlations between
gestational age and steroid hormone excretion or enzyme
activity were assessed using Spearman’s correlation anal-
ysis for normotensive and pre-eclamptic groups separately
and/or combined. Mann–Whitney U test was used to
analyse the subgroups, as appropriate according to
standard normality testing. Unpaired student’s t-test was
used to compare normotensive and pre-eclamptic groups
if standard normal distribution was confirmed. All the
statistical analyses were performed using SYSTAT version
11 (SYSTAT Software, Inc., Erkrath, Germany). Signifi-
cance was assigned at P!0.05.Results
Clinical characteristics
We recruited 95 infants at 3 months and 45 infants at
12 months, all from singleton pregnancies. A summary of
basic demographic data are given in Table 1. It can be seen
that gestation ages were comparable at both time
intervals.Cortisol metabolism at 3 and 12 months, related to
gestational week at delivery in infants born to
normotensive or pre-eclamptic mothers
As can be seen from Fig. 2, there was still a residual effect
of gestational age at delivery in relation to THS, THF and
total F metabolites (P!0.05), excretion being greater as
gestation progressed. This relationship was lost at 12
months (Supplementary Figure 1, see section on sup-
plementary data given at the end of this article). Figure 2
also shows summary data for cortisol and the various
metabolites in the normotensive and pre-eclamptic
groups. There was no difference in any of the measure-
ments of the adrenal cortisol axis. By the 12 month visit,This work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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Figure 2
Cortisol metabolites at 3 and 12 months after birth in infants born to
normotensive (3 months: nZ50; 12 months: nZ29;B or white bars) or
pre-eclamptic (3 months: nZ50; 12 months: nZ16;C or grey bars)
pregnancies, related to gestational week in infants. At 3 months, positive
associations were observed for (A) THS (rZ0.2225, PZ0.0302), (E) THF
(rZ0.2163, PZ0.0353) and (G) Total F (rZ0.2022, PZ0.0491) in the data
overall. Specific metabolites include (A and B) tetrahydro (TH)-metabolite
of deoxycortisol (S) (THS). (C and D) tetrahydro-E (THE); (E and F) TH-cortisol
(THF); (G and H) Total F metabolites and (I and J) Pregnandiol.
Data presented as median (IQR); *P!0.05; ***P!0.001.
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5–9 4 :237excretion of THS and THF had risen significantly in the
normotensive group (P!0.05 for both). THF had also risen
in the pre-eclamptic group (P!0.05). No difference was
observed either with respect to timing of the visit or with
respect to hypertensive status for F, THE or total F
metabolites (PO0.1 for all).
Pregnandiol excretion did not differ significantly at
either 3 or 12 months between normotensive and pre-
eclamptic groups. Both groups showed a rise in pregnan-
diol excretion between 3 and 12 months, which was
significant only in the normotensive group (P!0.05).Apparent enzyme activities relevant to cortisol
metabolism at 3 and 12 months, related to gestational
week in infants born to normotensive or pre-eclamptic
pregnancies
Figure 3A displays cortisol substrate delivery, B substrate
production, and C and D cortisol degradation.http://www.endocrineconnections.org
DOI: 10.1530/EC-15-0084
 2015 The authors
Published by Bioscientifica Ltd.Figure 3C and D shows that regardless of the putative
primary site of cortisol degradation (hepatic or renal),
there was still a significant residual effect of gestational age
at delivery. This did not differ between normotensive and
pre-eclamptic groups. It should be remembered that high
ratios represent low activities.
Figure 3A and B shows that at 3 months, gestational
age at delivery was not associated with either 17a-
hydroxylase or 11b-hydroxylase activity. No association
between gestational age and apparent 17a-hydroxylase
or 11b-hydroxylase activity was observed at 12 months
in infants born either from normotensive or pre-eclamptic
pregnancies (Supplementary Figure 1, see section on
supplementary data given at the end of this article).
Figure 3E and G show the metabolite ratios, at 3
months, were significantly lower in the pre-eclamptic
compared to normontensive controls, indicative of
higher 17a-hydroxylase and 11b-HSD activities of
tetrahydrometabolites.This work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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6–9 4 :238The significant increases in the metabolite ratios
between 3 and 12 months were indicative of lower
activities of all enzymes except 17a-hydroxylase activities
in the normotensive group (Fig. 3F, G and H). A similar
pattern was only seen in the pre-eclamptic group
for the two ratios indicative of 11b-HSD activities
(Fig. 3G and H). Thus, there was a significant difference
in the 11b-hydroxylase activity between normotensive
and pre-eclamptic groups at 12 months, which was not
present at 3 months (Fig. 3F).Discussion
This is one of the first studies of urinary cortisol
metabolites in infants through the first year of life using
highly sensitive and specific mass spectrometry-based
methodology. It provides data regarding infants exposed
to a pre-eclamptic or normotensive pregnancy. In this
analysis, the urinary excretion of individual cortisol
metabolites and combined cortisol metabolites at 3
months postnatally, still shows an effect of gestational
age at delivery in both groups. This highlights thehttp://www.endocrineconnections.org
DOI: 10.1530/EC-15-0084
 2015 The authors
Published by Bioscientifica Ltd.importance of taking into consideration gestational age
at delivery in the interpretation of steroid excretion, over
at least the first 3 months of postnatal life. The fetal
adrenal undergoes a maturational spurt between 32 and 34
weeks (31), considered to be preparing the fetus for birth,
as it is followed by the rapid maturation of a variety of
other hormone systems. Infants in our study born before
this time will not have been exposed to this, which may be
associated with compromised adrenal maturation.
The excretion of THS represents substrate availability:
in the normotensive group this rises between 3 and 12
months postnatally. THF also rises in parallel to this,
although 11b-hydroxylase activity has fallen in this group,
the substrate availability more than compensates. THF also
rises between 3 and 12 months in the pre-eclamptic group,
despite both substrate availability and 11b-hydroxylase
activity remaining almost constant over this time. How-
ever, the significant fall in both forms of 11b-HSD activity,
may have enabled this rise in THF. The increased apparent
11b-hydroxylase activity in the pre-eclamptic group by
comparison to the normotensive group at 12 months is
in line with the observed maintained F, THF and total FThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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7–9 4 :239excretion, despite the lower THS excretion. The lack of
increase over time of pregnandiol in the pre-eclamptic
group implies a lower substrate delivery.
In normotensive pregnancies, the increase in pre-
cursors and production of cortisol is to be expected as the
adrenal cortex develops from the fetal to the definitive
fasciculate zone (18) as can be seen Fig. 2 in response to
gestational age at delivery.
Reduced placental 11b-HSD activity, which has been
described before (32) does not translate into reduced
systemic apparent 11b-HSD activity during the first year of
life. Whereas we identified significant falls in both forms
of 11b-HSD activity in infants of both normotensive and
pre-eclamptic pregnancies during the first postnatal year,
Planck et al. investigating SGA infants aged between 2
and 13 years, could no longer identify major changes in
enzyme activities (33). Likewise, our previous data on
high placental cortisol availability in preterm gestation
(34) are not reflected in the cortisol production during the
first 12 months after birth, but could be a stimulus for the
high fetal 11b-HSD activity, which we found at 3 months.
Of interest, the reduced ACTH-induced stimulation of
cortisol release in preterm infants (35) was not reflected
by baseline cortisol production in our study.
Despite a rich literature on HPA maturation in
conditions such as intrauterine hypoxia with an excess
of cortisol (36), little information is available concerning
cortisol metabolites in the infants from pre-eclamptic
mothers. Our findings suggest that the steroid hormone
metabolism of preeclampsia does not reflect the profile
seen in hypoxia. The compromised upregulation of the
cortisol precursor, deoxycortisol could be due to the
availability of the major steroid hormone precursor
cholesterol, or its transport, might be affected due to pre-
eclamptic intrauterine conditions and placental dysfunc-
tion. This assumption is supported by a smaller increase in
pregnandiol in the pre-eclamptic group. Though the data
in early childhood are not available, data at birth indicate
reduced delivery of cholesterol to the fetus in IUGR and
pre-eclampsia (37, 38, 39). The potentially compromised
cholesterol transport due to fetal programming may
potentially contribute to later life vascular disease and
atherosclerosis in these infants (40).
As previously mentioned, by 3 months there was a
substantial dropout in attendance at the research unit,
which was exacerbated by 12 months. One of us (CR),
attempted to contact women at their homes, but there
were numerous logistical issues; part of these related to
collection of nappies. An additional limitation lay in the
use of pure cellulose nappies because of their reducedhttp://www.endocrineconnections.org
DOI: 10.1530/EC-15-0084
 2015 The authors
Published by Bioscientifica Ltd.capacity to absorb urine, thus complete 24-h collection
may not have been achieved. Incomplete voiding in these
very young infants might have led to limited comprehen-
sive or incomplete urine sampling. This limitation only
affects total steroid hormone amounts and not the ratios
derived. As muscle mass will be different in preterm and
term infants (41) and stability of creatinine was not tested
thoroughly for the nappies used at initial study entry, we
only provide absolute daily excretion of steroid hormones.
We could not control for a limited nappy volume, which
might be overwhelmed by strong voiding.
In conclusion, in infants born from pre-eclamptic
mothers, cortisol excretion is determined by an increase
in 11b-hydroxylase, which compensates for the high
11b-HSD-dependent cortisol degradation at 3 months.
This might still be present, after protecting the fetus from
high placental cortisol leakage during pre-eclamptic
conditions (34). The elevated apparent 11b-hydroxylase
at 12 months appears to counterbalance the reduced
substrate availability resulting in an unaltered total
cortisol metabolite excretion. Future research should be
directed to understand the role and development of
salvage mechanisms, such as reverse cholesterol transport
by enzymes such as the 27a-hydroxylase.Supplementary data
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